Walgreens Boots Alliance (NASDAQ:WBA)‘s stock had its “market perform” rating restated by equities research analysts at Wells Fargo & Co in a research note issued on Monday, MarketBeat Ratings reports. They presently have a $61.00 target price on the pharmacy operator’s stock, down from their previous target price of $65.00. Wells Fargo & Co‘s price objective would indicate a potential upside of 4.43% from the stock’s current price.

WBA has been the topic of a number of other research reports. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a research note on Thursday, October 3rd. ValuEngine upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Tuesday, December 3rd. JPMorgan Chase & Co. cut Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $73.00 to $63.00 in a report on Wednesday, October 23rd. Cleveland Research reaffirmed a “hold” rating on shares of Walgreens Boots Alliance in a research report on Monday, September 9th. Finally, BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $61.12.

WBA stock opened at $58.41 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.73 and a quick ratio of 0.36. The company has a fifty day moving average price of $58.91 and a two-hundred day moving average price of $54.63. Walgreens Boots Alliance has a one year low of $49.03 and a one year high of $83.33. The stock has a market cap of $52.33 billion, a price-to-earnings ratio of 9.75, a price-to-earnings-growth ratio of 1.46 and a beta of 0.88.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Monday, October 28th. The pharmacy operator reported $1.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.02. The company had revenue of $33.95 billion for the quarter, compared to analyst estimates of $33.88 billion. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The company’s revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.48 earnings per share. Research analysts anticipate that Walgreens Boots Alliance will post 5.93 EPS for the current fiscal year.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $63.16, for a total transaction of $14,801,861.80. Following the sale, the chief accounting officer now directly owns 13,844 shares of the company’s stock, valued at approximately $874,387.04. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 15.73% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in WBA. Taylor Hoffman Wealth Management increased its holdings in shares of Walgreens Boots Alliance by 360.0% in the third quarter. Taylor Hoffman Wealth Management now owns 460 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 360 shares in the last quarter. Quest Capital Management Inc. ADV bought a new stake in Walgreens Boots Alliance during the third quarter worth about $31,000. First Interstate Bank boosted its holdings in shares of Walgreens Boots Alliance by 228.1% in the 2nd quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 422 shares in the last quarter. TRUE Private Wealth Advisors acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth approximately $38,000. Finally, Golden State Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth $38,000. Institutional investors and hedge funds own 60.09% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: What does it mean to hold a stock in street name?

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.